Clinical Trials Logo

Prediabetes clinical trials

View clinical trials related to Prediabetes.

Filter by:
  • Not yet recruiting  
  • « Prev · Page 5

NCT ID: NCT02960373 Not yet recruiting - Diabetes Mellitus Clinical Trials

Dried Fruit and Postprandial Glycemia Trial

Start date: November 2016
Phase: N/A
Study type: Interventional

Dried fruits show promising potential for the management of blood glucose. Previous trials have reported beneficial effects of raisins on post-prandial glucose and insulin responses in healthy individuals when compared with white bread. However, to date there is limited data evaluating the potential beneficial effects of other dried fruits (i.e. sultanas, dates and apricots). It is also unclear whether dried fruits can be used to lower the postprandial glycemic responses to high-GI carbohydrate foods by either displacing available carbohydrate (displacement effect) or providing 'catalytic' doses of fructose ('catalytic' fructose effect). To address these questions, the investigators propose to assess the GI of 4 common types of dried fruit (raisins, sultanas, dates, apricots) (GI effect) and their ability to decrease the postprandial glycemic response to white bread by either partially displacing available carbohydrate (displacement effect) or by providing a 'catalytic' dose of fructose ('catalytic' fructose effect).

NCT ID: NCT01869101 Not yet recruiting - Prediabetes Clinical Trials

Prospective Observational Study Assessing Treatment and Outcomes of Patients With Prediabetes

Start date: June 2013
Phase: N/A
Study type: Observational

The purpose of this observational study is to assess the treatment and outcomes of patients with prediabetes in community-based clinical practices.

NCT ID: NCT01659697 Not yet recruiting - Prediabetes Clinical Trials

Diabetes Prevention in Prediabetic Patients

DPEP
Start date: August 2012
Phase: N/A
Study type: Observational

This study will evaluate the feasibility and efficacy of two interventions of lifestyle ( intensive and less intensive) to prevent diabetes in patients from Ethiopian origin, aged 25 to 55 years old with prediabetes living in Israel and insured by Clalit Health Services in the Central district, using resources existing in this Health Care system (HMO).